Navigation Links
Arete Therapeutics Initiates Phase IIa Clinical Trial for AR9281, a Novel s-EH Inhibitor to Treat Type 2 Diabetes
Date:2/10/2009
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2009)... ActingSecretaryEncouragesUseofPAPreferredProducts...ire-USNewswire/--ToensurethatyourfamilyhasasafeTha...ssellReddingisurgingresidentstofollowafewbasicfood.... ,, "Followingandunderstandingproperfoodhandli...ureyourThanksgivingdinnerissafetoeat,"saidRedding....
(Date:11/23/2009)... WASHINGTON,Nov.23/PRNewswire-USNewswire/--TheAmer...lchildren,spublishing,education,andmediacompany,ar...cecurriculumdesignedtosparkinterestinthefieldsofsc...itingcareeropportunitiesinhematology. ,, "Manyh...olaboutHemotheMagnificent,whichmadelearningaboutbl...
(Date:11/23/2009)...AND, Ore. Low-income children who don,t access he... long term are significantly more likely to have u...ording to a new study published in the journal Pe...nforming the financing and delivery of quality hea... "In the current policy debates about health insu...
(Date:11/23/2009)...ales saw their odds drop by 63 percent with modera..., Nov. 23 (HealthDay News) -- Moderate-to-high int...s may help reduce stroke risk in older men but not...uded almost 3,300 men and women, average age 69, i.... During that time, there were 238 strokes among t...
(Date:11/23/2009)...nadine Healy, first woman to head the agency, said... 23 (HealthDay News) -- The fallout from last week...he start of routine mammogram testing for breast c...tional Institutes of Health advising women to igno...y ignore them, because unequivocally this will inc...
Breaking Medicine News(10 mins):Health News:Pennsylvania Agriculture Department Encourages Proper Food Handling, Offers Safety Tips for Thanksgiving 2Health News:New Science Program Teaches High School Students About Blood and Career Opportunities in the Field of Hematology 2Health News:New Science Program Teaches High School Students About Blood and Career Opportunities in the Field of Hematology 3Health News:Children who lack continuity with a regular health care provider miss needed services 2Health News:Children who lack continuity with a regular health care provider miss needed services 3Health News:Vigorous Exercise Cuts Stroke Risk for Men, Not Women 2Health News:Women Should Ignore New Mammogram Guideline, Ex-NIH Chief Says 2Health News:Women Should Ignore New Mammogram Guideline, Ex-NIH Chief Says 3
...cians to Share Imaging Stories , , WASHINGTON, M...IC) today unveiled RightScanRightTime.org , a n...g community,s support for public policy that ensur...epresenting more than 100,000 physicians, medical ...
...ampaign for Tobacco-Free Kids , , WASHINGTON, May...toric victory for health and the public,s right to...almost all workplaces, including all restaurants a...te to pass a strong smoke-free law that includes a...
...s safe places, but today they are becoming one of ... best of economic times, security is not the top p... an easy place to cut budget and staff. John Adam... hospital crime firsthand. His company is respons...
...w of more than 2,000 patients coded for Barrett,s ...prevalence of the disease according to researchers...of patients assigned a billing diagnosis code for ...esophagus by contrasting codes from electronic dat...
...KE FOREST, Ill., May 14 Hospira, Inc. (NYSE: HS... medication delivery company, today held its 2009 ...e agenda included votes on three items and an upda...4, a testament to the strong foundation we have es...
...Now On Sale , , DENVER, May 14 arc Thrift Store...s that support people with developmental disabilit... on Friday, June 19th, 2009. Co-chairs Cleo Parker...live with physical and cognitive disabilities. One...
Other Medicine News:Health News:AMIC Unveils RightScanRightTime.org 2Health News:Approval of Wisconsin Smoke-Free Legislation Is Historic Win for Health 2Health News:Top Five Things Hospitals Need to do in Order to Remain Safe and Secure 2Health News:Study examines reliability of clinical and pathological diagnoses of Barrett's esophagus 2Health News:Study examines reliability of clinical and pathological diagnoses of Barrett's esophagus 3Health News:Study examines reliability of clinical and pathological diagnoses of Barrett's esophagus 4Health News:Study examines reliability of clinical and pathological diagnoses of Barrett's esophagus 5Health News:Hospira Highlights Five Years of Progress and Future Opportunities at Its 2009 Annual Meeting of Shareholders 2Health News:arc Thrift Stores to Honor Individuals and Businesses Who Support People With Developmental Disabilities 2
(Date:11/23/2009)...wswire-FirstCall/-- CryoLife,Inc. (NYSE: CRY ),ani...tissueprocessingcompany,announcedtodaythatitissche...ualHealthCareConferenceatTheNewYorkPalaceHotelonDe...hiefexecutiveofficerofCryoLife,Inc.,willprovideaco...ntsandhostaquestionandanswersessionat4:30p.m.Easte...
(Date:11/23/2009)....23/PRNewswire-FirstCall/--WoundManagementTechnolo...oviderofspecialtymedicalproducts,announcedthatitha...ehensivemanagementbusinessupdatetoillustratethedev...alesincreased33.5%to$102,926vs.Q32008salesof$77,08...o$3,327,892vs.Q32008shareholderequityof$(321,257) ...
(Date:11/23/2009)...23/PRNewswire-FirstCall/--Pharmasset,Inc.(Nasdaq: ...byitspartnerRoche(SWX:ROG.VX;RO.S,OTCQX:RHHBY),wil...theongoingphase2btrialofRG7128,afirst-in-classnucl...ronichepatitisCvirus(HCV)infection.Thedecisionwasr...toringCommittee(DMC)ofallavailablesafetydatafromth...
Breaking Medicine Technology:CryoLife to Present at 21st Annual Piper Jaffray Health Care Conference 2Wound Management Technologies (OTCBB: WNDM) Reports Revenue Increase of 33.5%; Posts Evidence-Based Studies for CellerateRx; and Business Update 2Wound Management Technologies (OTCBB: WNDM) Reports Revenue Increase of 33.5%; Posts Evidence-Based Studies for CellerateRx; and Business Update 3Wound Management Technologies (OTCBB: WNDM) Reports Revenue Increase of 33.5%; Posts Evidence-Based Studies for CellerateRx; and Business Update 4Wound Management Technologies (OTCBB: WNDM) Reports Revenue Increase of 33.5%; Posts Evidence-Based Studies for CellerateRx; and Business Update 5Pharmasset Announces the Continued Enrollment of the Phase 2b Clinical Trial of RG7128 for the Treatment of Hepatitis C 2Pharmasset Announces the Continued Enrollment of the Phase 2b Clinical Trial of RG7128 for the Treatment of Hepatitis C 3Pharmasset Announces the Continued Enrollment of the Phase 2b Clinical Trial of RG7128 for the Treatment of Hepatitis C 4Children Uniting Nations Russell Simmons Mos Def David Archuleta Terrence Howard Gabrielle Union Vivica Fox Elise Neal and Shawn King Visit 48163 1Children Uniting Nations Russell Simmons Mos Def David Archuleta Terrence Howard Gabrielle Union Vivica Fox Elise Neal and Shawn King Visit 48163 2RiskMetrics Recommends That Providence Service Corporation Stockholders Vote for Providences Director Nominees on the White Proxy Card 48161 1RiskMetrics Recommends That Providence Service Corporation Stockholders Vote for Providences Director Nominees on the White Proxy Card 48161 2RiskMetrics Recommends That Providence Service Corporation Stockholders Vote for Providences Director Nominees on the White Proxy Card 48161 3RiskMetrics Recommends That Providence Service Corporation Stockholders Vote for Providences Director Nominees on the White Proxy Card 48161 4RiskMetrics Recommends That Providence Service Corporation Stockholders Vote for Providences Director Nominees on the White Proxy Card 48161 5RiskMetrics Recommends That Providence Service Corporation Stockholders Vote for Providences Director Nominees on the White Proxy Card 48161 6CVS Caremark Ranks Among 50 Best Fertility and Adoption Friendly Workplaces in America 48156 1CVS Caremark Ranks Among 50 Best Fertility and Adoption Friendly Workplaces in America 48156 2CVS Caremark Ranks Among 50 Best Fertility and Adoption Friendly Workplaces in America 48156 3
... an emerging,research-based pharmaceutical company...ation (FDA) has granted Orphan Drug Designation to...tment of chronic lymphocytic,leukemia (CLL). A Pha...ic,in Rochester, Minnesota where researchers are s...henon E in CLL patients., "The FDA Orphan Drug De...
...a,Pharmaceuticals, Inc. (Nasdaq: ALXA ) announced...inical trial with AZ-004 (Staccato(R) loxapine).,A...eloped for the treatment,of acute agitation in pat...za believes the novel, non-invasive nature and rap...inhaled loxapine administration via the,Staccato s...
Other Medicine Technology:Polyphenon Pharma Receives Orphan Drug Designation for Its Botanical Drug, Polyphenon E, for the Treatment of CLL 2Alexza Initiates Second Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine) 2Alexza Initiates Second Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine) 3Alexza Initiates Second Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine) 4Alexza Initiates Second Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine) 5Alexza Initiates Second Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine) 6
...al chip technology, the new IMAGEnet 2000 Super Hi... 3,072 x 2,048 pixels resolution and a 12-bit dyna...des exceptionally sharp and detailed images. It al...ilitates instant diagnosis by allowing the instant...
Multi-functional spectral transmittance meter
Topcon TLS-FD trial lens set
AIT-250W instrument table
Medicine Products: